PruEV‐AI: a Simple Approach Combines Urinary Extracellular Vesicle Isolation with AI‐Assisted Analysis for Prostate Cancer Diagnosis
Small Methods · 2026-01 · 10 (2)
DOI: 10.1002/smtd.202500659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, online erschienen am 23.06.2025. Verfasst von Minju Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Extracellular Vesicles, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Urinary extracellular vesicles (uEVs) are a promising source of prostate‐derived biomarkers for non‐invasive prostate cancer (PCa) diagnosis. However, conventional uEV isolation methods and single‐marker assays often lack efficiency and diagnostic accuracy. Here, PruEV‐AI is introduced, an integrated diagnostic system that combines rapid uEV isolation with AI‐based biomarker analysis. The PruEV platform employs amine‐modified zeolites (AZ) and carbohydrazide (CDH) to isolate uEVs and extract miRNAs in less than 30 min through electrostatic and covalent interactions. This one‐step syringe‐filter process enables high‐throughput, reproducible, and user‐friendly isolation of uEVs suitable for clinical diagnostics. Among 12 candidate miRNAs, 6 are validated using RT‐qPCR in urine samples from 48 PCa patients and 49 controls. Individually, these miRNAs and PSA show modest diagnostic performance, with area under the curve (AUC) values ranging from 0.6 to 0.8. To overcome the limitations of single biomarkers, a deep learning (DL) model evaluates all 127 possible combinations of the 6 miRNAs and PSA. The optimal biomarker combination identified by the DL model achieves an AUC of 0.9556, with 93.33% sensitivity, specificity, and accuracy. Consequently, the PruEV‐AI system provides a robust, non‐invasive, and clinically relevant diagnostic approach for accurately identifying PCa, thereby supporting improved screening protocols and more effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
- Division of Biomedical Metrology, Korea Research Institute of Standards and Science, Daejeon, 34114, Republic of Korea.
- Department of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin, 17035, Republic of Korea.
- Department of Urology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, 07985, Republic of Korea.
ORCID-Profile: Yong Shin
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, M., Koo, B., Kim, M. G., Lee, H. J., Lee, E. Y., Roh, Y., Bae, C. E., Park, S., Qiao, Z., Kim, I. H., Woo, M. K., Kim, C. S., & Shin, Y. (2026). PruEV‐AI: a Simple Approach Combines Urinary Extracellular Vesicle Isolation with AI‐Assisted Analysis for Prostate Cancer Diagnosis. Small Methods, 10(2). https://doi.org/10.1002/smtd.202500659
Vancouver
Lee M, Koo B, Kim MG, Lee HJ, Lee EY, Roh Y, et al. PruEV‐AI: a Simple Approach Combines Urinary Extracellular Vesicle Isolation with AI‐Assisted Analysis for Prostate Cancer Diagnosis. Small Methods. 2026;10(2). doi:10.1002/smtd.202500659
BibTeX
@article{Lee2026,
author = {Lee, Minju and Koo, Bonhan and Kim, Myoung Gyu and Lee, Hyo Joo and Lee, Eun Yeong and Roh, Yeonjeong and Bae, Chae Eun and Park, Seungil and Qiao, Zhen and Kim, Il-Hwan and Woo, Myung Kyun and Kim, Choung-Soo and Shin, Yong},
title = {PruEV‐AI: a Simple Approach Combines Urinary Extracellular Vesicle Isolation with AI‐Assisted Analysis for Prostate Cancer Diagnosis},
journal = {Small Methods},
year = {2026},
volume = {10},
number = {2},
doi = {10.1002/smtd.202500659}
}
EUVIMED